What is elomirces?

Elomirces is a novel investigational drug developed for the treatment of Alzheimer's disease. It acts as a dual mechanism therapy, targeting both amyloid-beta plaques and tau proteins, which are key contributors to the disease's progression. By addressing these pathological hallmarks, elomirces aims to improve cognitive function and slow the decline associated with Alzheimer's. Clinical trials are ongoing to evaluate its efficacy and safety.